Perrigo
Rating
Updated: Aug 12, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Sel...
Latest News
18 days ago · zacks.com
Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
26 days ago · prnewswire.com
Perrigo to Attend the Barclays Global Consumer ConferenceDUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Barclays Global Consumer Conference on Thursday, September 10th, 2026. About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe.
27 days ago · zacks.com
PRGO or NEOG: Which Is the Better Value Stock Right Now?Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
27 days ago · zacks.com
Should Value Investors Buy Perrigo (PRGO) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
1 month ago · seekingalpha.com
Perrigo: The Rebound Is Just Getting StartedPerrigo Company remains substantially undervalued, with a Buy rating justified by strong income and growth potential. Recent quarterly EPS and revenue beats, coupled with market share gains, signal improving fundamentals despite a soft OTC market. Management's focus on cost control, debt reduction, and dividend growth underpins a compelling 16–21% expected annual total return.
1 month ago · zacks.com
PRGO vs. NEOG: Which Stock Is the Better Value Option?Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks?
1 month ago · zacks.com
Are Investors Undervaluing Perrigo (PRGO) Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2 months ago · seekingalpha.com
Perrigo Company plc (PRGO) Q2 2026 Earnings Call TranscriptPerrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript
2 months ago · zacks.com
Perrigo (PRGO) Reports Q2 Earnings: What Key Metrics Have to SayThe headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2 months ago · zacks.com
Perrigo (PRGO) Surpasses Q2 Earnings and Revenue EstimatesPerrigo (PRGO) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.57 per share a year ago.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove PRGO